Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Level BiotechnologyROCO:3118 76 Dividend Yield % is 6.93% as of Jul. 21, 2026, which is 26% above its 10-year median of 5.52. GuruFocus rates ROCO:3118 with a GF Score™ of 76/100 and a GF Value™ of NT$35.57 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 153 Biotechnology companies, Level Biotechnology ranks better than 93.46% on this metric.
As of today (2026-07-21), the Trailing Annual Dividend Yield of Level Biotechnology is 6.93%.
Good Sign:
Level Biotechnology Inc stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for Level Biotechnology's Dividend Yield % or its related term are showing as below:
ROCO:3118'
s Dividend Yield % Range Over the Past 10 Years
Min: 2.64 Med: 5.52 Max: 13.33
Current: 6.93
During the past 13 years, the highest Dividend Yield of Level Biotechnology was 13.33%. The lowest was 2.64%. And the median was 5.52%.
ROCO:3118's Dividend Yield % is ranked better than 93.46% of 153
companies
in the Biotechnology industry
Industry Median: 1.34
vs ROCO:3118: 6.93
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Level Biotechnology Inc is 0.74, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Level Biotechnology was 1.50. The lowest was 0.69. And the median was 0.86.
During the past 12 months, Level Biotechnology's average Dividends Per Share Growth Rate was 5.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -1.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -1.30% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Level Biotechnology was 23.90% per year. The lowest was -23.10% per year. And the median was 2.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Level Biotechnology Dividend Yield % Related Terms
Level Biotechnology Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Level Biotechnology's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:3118 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Level Biotechnology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Level Biotechnology Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Level Biotechnology's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Level Biotechnology's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Level Biotechnology Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 2.200000
2026-06-10
2026-06-11
2026-07-03
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Level Biotechnology's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Level Biotechnology (ROCO:3118) has a Dividend Yield % of 6.93% as of Jul. 21, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Level Biotechnology and its competitors. This is 26% above median its historical median of 5.52. Over the past decade, Level Biotechnology's Dividend Yield % has ranged from 2.64 to 13.33. According to the industry distribution chart, Level Biotechnology ranks #10 out of 153 companies in the Biotechnology industry, placing it in the top 6.5%.
Is Level Biotechnology's Dividend Yield % too high?
Level Biotechnology's current Dividend Yield % of 6.93% is 26% above median its 10-year median of 5.52. Over the past 10 years, this metric has ranged from a low of 2.64 to a high of 13.33. The Biotechnology industry median Dividend Yield % is 1.34. Level Biotechnology's value of 6.93% is 417.2% above this industry median. Based on the distribution chart, Level Biotechnology ranks #10 out of 153 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Level Biotechnology has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Level Biotechnology's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Level Biotechnology ranks #10 out of 153 companies for Dividend Yield %. This places Level Biotechnology in the top 7% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.34. Level Biotechnology's value of 6.93% is 417.2% above this benchmark. Historically, Level Biotechnology's own Dividend Yield % has ranged from 2.64 to 13.33 over the past decade. While the company's 10-year median is 5.52 vs. the industry median of 1.34, Level Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.34, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Level Biotechnology's current Dividend Yield % of 6.93% is 417.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Level Biotechnology and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Level Biotechnology's current Dividend Yield % is 6.93%, which is 26% above median its own 10-year median of 5.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Level Biotechnology (ROCO:3118) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$35.57, compared to a current price of NT$31.75 — trading 10.7% below its estimated fair value. The current Dividend Yield % is 6.93%, which is 26% above median its 10-year median of 5.52 and 417.2% above the Biotechnology industry median of 1.34. Level Biotechnology's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Level Biotechnology (ROCO:3118), the current Dividend Yield % is 6.93% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Level Biotechnology (ROCO:3118) Overvalued in 2026?
Based on GuruFocus' analysis, Level Biotechnology stock appears to be undervalued.
The current stock price of NT$31.75 is trading 10.7% below its estimated GF Value™ of NT$35.57.
GuruFocus considers Level Biotechnology to be Modestly Undervalued.
Key valuation signals for ROCO:3118:
Dividend Yield %: 6.93% (26% above median its 10-year median of 5.52)
GF Value™: NT$35.57 vs. price of NT$31.75 (10.7% below fair value)
Industry Position: 417.2% above the Biotechnology median (#10 of 153)
No single metric tells the full story. See the ROCO:3118 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services. The company has three reportable segments: Department A and B, Department C, and Department D. Department A and Department B sell the cell culture consumables and the antibody reagents, Department C sells the instruments and equipment, and Department D provides CRO services. The majority of revenue is derived from the Department A and B.
76GF Score
Get the complete analysis for ROCO:3118
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:3118 has been successfully added to your 
